(redirected from Botulinum Neurotoxin Type A)
BNTABritish Numismatic Trade Association
BNTABureau de Normalisation des Tubes d'Acier (French: Steel Tubes Standardization Bureau)
BNTABotulinum Neurotoxin Type A (microbiology)
BNTABirmingham National Trust Association (UK)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
Tamburin, "Botulinum neurotoxin type a for the treatment of pain: not just in migraine and trigeminal neuralgia," Journal of Headache and Pain, vol.
The intraprostatic injection of botulinum neurotoxin type A (BoNT-A) is a minimally invasive usage of the drug to treat benign prostatic hyperplasia (BPH) and subsequent lower urinary tract symptoms (LUTS).
The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant, autonomic neuromuscular transmission.
Johnson, "Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination," Journal of Pharmacological and Toxicological Methods, vol.
Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity.
Crystal structure of botulinum neurotoxin type A and implications for toxicity.
Dott, "Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle," Toxicon, vol.
-- Antibodies against botulinum toxins, led by XOMA 3AB, a novel combination of three antibodies to prevent and treat botulism poisoning caused by exposure to botulinum neurotoxin Type A, among the most deadly bioterror threats.
The new cell-based potency assay for BOTOX and BOTOX Cosmetic is specific to Allergan's formulation of botulinum neurotoxin type A.
Effects of purification on the bioavailability of botulinum neurotoxin type A. Toxicology 2008; 249:123-9.